Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
51 hedge funds and large institutions have $427M invested in Shockwave Medical, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 51 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$123M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$62.9M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$44.3M |
| 4 |
VMI
VHCP Management II
New York
|
+$29.9M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$28.2M |
Top Sellers
SWAV Hedge Fund Activity: Q1 2019 in Review
51 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q1 2019, worth a combined $427M.
Buyers outnumbered sellers: 51 funds opened new SWAV positions and 0 closed out — a net gain of 51 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $123M.
- 51 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q1 2019, up from 0 in Q4 2018.
- Funds reported $427M of Shockwave Medical, Inc. Common Stock stock for Q1 2019.
- 51 funds opened new Shockwave Medical, Inc. Common Stock positions in Q1 2019 and 0 closed out, a net change of +51 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q1 2019 was Fidelity Investments, an estimated $123M added.
Based on aggregated 13F filings for Q1 2019.